Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambulatory blood pressure comparison of olmesartan vs valsartan and their combinations with hydrochlorothiazide in moderate hypertension
2005-004380-32Phase 3Active
- Sponsor
- University of Pavia
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of olmesartan, valsartan and hydrochlorothiazide in essential hypertension (4 arms), sponsored by University of Pavia. Primary endpoint: Primary antihypertensive efficacy. Started Jan 2007; status: active.
02
Drugs
olmesartanvalsartanhydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2005-004380-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004380-32.